CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Cipla USA, Inc. recalls Lanthanum Carbonate chewable tablets

Read the official FDA notice

Published
17 Dec 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Failed stability specifications: Out of specification for hardness test

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13.

Brand / company
Cipla USA, Inc.
Codes / lots
lot# NB240315, exp 12/31/2025 | Lot# NB240314, exp 12/31/2025
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 17 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.